NARA Discovery
Article Details
← Back to Search Results
Journal Article

Shorter, warmer winters may inhibit production of ephyrae in a population of the moon jellyfish Aurelia aurita

Alexandra Loveridge; Cathy H. Lucas; Kylie A. Pitt
Hydrobiologia · Vol. 848, Issue 3 · pp. 739-749 · 2021

Abstract

Scyphozoan jellyfish blooms display high interannual variability in terms of timing of appearance and size of the bloom. To understand the causes of this variability, the conditions experienced by the polyps prior to the production of ephyrae in the spring were examined. Polyps reared from planula larvae of Aurelia aurita medusae collected from southern England (50°49′58.8; − 1°05′36.9) were incubated under orthogonal combinations of temperature (4, 7, 10 °C) and duration (2, 4, 6, 8 weeks), representing the range of winter conditions in that region, before experiencing an increase to 13 °C. Timing and success of strobilation were recorded. No significant production of ephyrae was observed in any of the 2- and 4-week incubations, or in any 10 °C incubation. Time to first ephyra release decreased with longer winter incubations, and more ephyrae were produced following longer and colder winter simulations. This experiment indicates that A. aurita requires a minimum period of cooler temperatures to strobilate, and contradicts claims that jellyfish populations will be more prevalent in warming oceans, specifically in the context of warmer winter conditions. Such investigations on population-specific ontogeny highlights the need to examine each life stage separately as well as in the context of its environment.

Bibliographic Information

JournalHydrobiologia
PublisherSpringer
Publication Date2021-02-01
Publication Year2021
Volume848
Issue3
Pages739-749
Document TypeJournal Article
Print ISSN0018-8158
eISSN1573-5117
DOI10.1007/s10750-020-04483-9

Access Information

NARA Access Coverage1948-01-01~Current
Journal Homepagehttps://www.springer.com/journal/10750
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.